Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2006

01-11-2006 | Poster Presentation

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?

Authors: ML Murphy, SKW Chan, L Bazley, NVL Hayes, WJ Gullick

Published in: Breast Cancer Research | Special Issue 2/2006

Login to get access

Excerpt

The purpose of this study is to explore possible molecular and cellular mechanisms involved in the development of resistance to Herceptin in breast cancer patients. …
Metadata
Title
Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
Authors
ML Murphy
SKW Chan
L Bazley
NVL Hayes
WJ Gullick
Publication date
01-11-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1590

Other articles of this Special Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue

Oral Presentation

Aberrant activation of Notch signalling in human breast cancer

Poster Presentation

Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis

Poster Presentation

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes

Poster Presentation

The emerging role of CD44 in regulating skeletal metastasis

Poster Presentation

'I haven't had breast cancer but I've had a mastectomy anyway': do women with ductal carcinoma in situhave appearance concerns?

Poster Presentation

Breast cancer in relation to childhood parental divorce and early adult psychiatric disorder in a British birth cohort
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits